GT Biopharma, Inc. reports

Company location: San Francisco, CA
Fiscal year end: 31 December

GT Biopharma, Inc. has filed 875 SEC EDGAR filings since 12 May 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 401-425 of 516 matching filings.

Per page

Current page

S-1 File 333-213270

OXIS FORM S-1

Filing date: 24 Aug 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-08092

QUARTERLY REPORT

Filing date: 10 Aug 2016
Reporting date: 30 Jun 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-08092

OXIS 8-K ISSUANCE OF DEBENTURE

Filing date: 09 Aug 2016
Reporting date: 09 Aug 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

CURRENT REPORT

Filing date: 17 Jun 2016
Reporting date: 13 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

CURRENT REPORT

Filing date: 03 Jun 2016
Reporting date: 27 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-08092

QUARTERLY REPORT

Filing date: 13 May 2016
Reporting date: 31 Mar 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

OWNERSHIP DOCUMENT

Filing date: 05 Apr 2016
Reporting date: 04 Apr 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-32837

AMENDMENT NO. 7

Filing date: 05 Apr 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-08092

ANNUAL REPORT

Filing date: 30 Mar 2016
Reporting date: 31 Dec 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

OWNERSHIP DOCUMENT

Filing date: 02 Mar 2016
Reporting date: 09 Feb 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 23 Feb 2016
Reporting date: 25 Jan 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

OXIS 8-K AMENDMENT OF NOTE CONVERSION AGREEMENT

Filing date: 19 Feb 2016
Reporting date: 19 Feb 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-32837

NONE

Filing date: 18 Feb 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 12 Feb 2016
Reporting date: 25 Jan 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-32837

NONE

Filing date: 09 Feb 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-32837

SCHEDULE 13G

Filing date: 26 Jan 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-32837

AMENDED SCHEDULE 13D

Filing date: 26 Jan 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3

Filing date: 25 Jan 2016
Reporting date: 13 Jan 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-32837

SCHEDULE 13G AMENDMENT

Filing date: 25 Jan 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

OXIS 8-K SALE OF UNREGISTERED SECURITIES

Filing date: 22 Jan 2016
Reporting date: 19 Jan 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

CURRENT REPORT

Filing date: 08 Jan 2016
Reporting date: 08 Jan 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-08092

QUARTERLY REPORT

Filing date: 13 Nov 2015
Reporting date: 30 Sep 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-08092

CURRENT REPORT

Filing date: 26 Oct 2015
Reporting date: 26 Oct 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

OXIS 8-K DR. VALLERA LICENSE

Filing date: 08 Sep 2015
Reporting date: 03 Sep 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-08092

QUARTERLY REPORT

Filing date: 14 Aug 2015
Reporting date: 30 Jun 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing